Kewaunee Scientific 미래 성장

Future 기준 확인 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Kewaunee Scientific.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Medical Equipment 수익 성장	17.4%
매출 성장률	n/a
향후 자기자본 수익률	n/a
애널리스트 커버리지	None
마지막 업데이트	n/a

최근 미래 성장 업데이트

업데이트 없음

Recent updates

The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out

Sep 24

Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Sep 17

With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Sep 10

Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Aug 23

Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Jul 11

Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Jun 19

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Dec 18

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Jul 02

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Kewaunee Scientific 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

NasdaqGM:KEQU - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
7/31/2024	202	18	8	11	N/A
4/30/2024	204	19	15	20	N/A
1/31/2024	201	9	12	18	N/A
10/31/2023	215	7	0	6	N/A
7/31/2023	219	4	-5	1	N/A
4/30/2023	219	1	-8	-4	N/A
1/31/2023	215	-1	-13	-10	N/A
10/31/2022	195	-3	-4	-2	N/A
7/31/2022	180	-6	-4	-2	N/A
4/30/2022	169	-6	-10	-8	N/A
1/31/2022	158	-9	-5	-3	N/A
10/31/2021	151	-7	-7	-5	N/A
7/31/2021	151	-4	0	2	N/A
4/30/2021	147	-4	-1	1	N/A
1/31/2021	143	-2	0	3	N/A
10/31/2020	144	-4	-4	-1	N/A
7/31/2020	145	-6	-1	1	N/A
4/30/2020	148	-5	2	4	N/A
1/31/2020	148	-5	-1	3	N/A
10/31/2019	146	-3	1	5	N/A
7/31/2019	144	1	0	5	N/A
4/30/2019	147	2	-2	2	N/A
1/31/2019	156	4	5	8	N/A
10/31/2018	162	5	4	8	N/A
7/31/2018	166	6	-4	0	N/A
4/30/2018	158	5	N/A	3	N/A
1/31/2018	148	5	N/A	5	N/A
10/31/2017	140	5	N/A	7	N/A
7/31/2017	135	4	N/A	12	N/A
4/30/2017	139	5	N/A	12	N/A
1/31/2017	138	4	N/A	10	N/A
10/31/2016	140	5	N/A	8	N/A
7/31/2016	135	4	N/A	6	N/A
4/30/2016	129	4	N/A	7	N/A
1/31/2016	125	3	N/A	-1	N/A
10/31/2015	120	3	N/A	-3	N/A
7/31/2015	119	3	N/A	4	N/A
4/30/2015	119	4	N/A	2	N/A
1/31/2015	116	4	N/A	7	N/A
10/31/2014	114	4	N/A	9	N/A
7/31/2014	110	4	N/A	6	N/A
4/30/2014	111	4	N/A	8	N/A
1/31/2014	116	4	N/A	6	N/A

애널리스트 미래 성장 예측

수입 대 저축률: Insufficient data to determine if KEQU's forecast earnings growth is above the savings rate (2.5%).

수익 vs 시장: Insufficient data to determine if KEQU's earnings are forecast to grow faster than the US market

고성장 수익: Insufficient data to determine if KEQU's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: Insufficient data to determine if KEQU's revenue is forecast to grow faster than the US market.

고성장 수익: Insufficient data to determine if KEQU's revenue is forecast to grow faster than 20% per year.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: Insufficient data to determine if KEQU's Return on Equity is forecast to be high in 3 years time

Kewaunee Scientific 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

Recent updates

The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out

Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Kewaunee Scientific Corporation to Report Q1, 2025 Results on Sep 11, 2024

Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Kewaunee Scientific Corporation, Annual General Meeting, Aug 28, 2024

Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Kewaunee Scientific Corporation to Report Q4, 2024 Results on Jun 26, 2024

Investor sentiment improves as stock rises 18%

Vice President of Human Resources recently sold US$107k worth of stock

Insider recently sold US$93k worth of stock

Insider notifies of intention to sell stock

Third quarter 2024 earnings released: EPS: US$0.87 (vs US$0.26 in 3Q 2023)

Kewaunee Scientific Corporation to Report Q3, 2024 Results on Mar 06, 2024

Investor sentiment improves as stock rises 18%

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

President recently sold US$137k worth of stock

President notifies of intention to sell stock

Investor sentiment improves as stock rises 36%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: US$0.94 (vs US$0.086 loss in 2Q 2023)

Kewaunee Scientific Corporation to Report Q2, 2024 Results on Dec 06, 2023

First quarter 2024 earnings released: EPS: US$0.86 (vs US$0.27 loss in 1Q 2023)

Kewaunee Scientific Corporation, Annual General Meeting, Aug 23, 2023

New minor risk - Shareholder dilution

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

President exercised options and sold US$92k worth of stock

New minor risk - Insider selling

Insider recently bought US$657k worth of stock

Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Third quarter 2023 earnings released: EPS: US$0.26 (vs US$0.47 loss in 3Q 2022)

Second quarter 2023 earnings released: US$0.086 loss per share (vs US$1.11 loss in 2Q 2022)

Insufficient new directors

First quarter 2023 earnings released: US$0.27 loss per share (vs US$0.48 loss in 1Q 2022)

Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M

Kewaunee Scientific Corporation, Annual General Meeting, Aug 24, 2022

Full year 2022 earnings released: US$2.20 loss per share (vs US$1.33 loss in FY 2021)

Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M

Insider recently bought US$421k worth of stock

Insufficient new directors

Insufficient new directors

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Kewaunee Scientific Corporation announced delayed 10-Q filing

First quarter 2022 earnings released: US$0.48 loss per share (vs US$0.22 loss in 1Q 2021)

Full year 2021 earnings released: US$1.33 loss per share (vs US$1.70 loss in FY 2020)

Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Third quarter 2021 earnings released: EPS US$0.029 (vs US$0.70 loss in 3Q 2020)

Kewaunee Scientific Corporation to Report Q3, 2021 Results on Mar 10, 2021

New 90-day high: US$13.37

New 90-day high: US$12.56

Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

New 90-day high: US$9.79

Second quarter 2021 earnings released: US$0.065 loss per share

Kewaunee Scientific reports Q2 results

New 90-day high: US$9.75

Kewaunee Scientific Corporation to Report Q2, 2021 Results on Dec 09, 2020

New 90-day low: US$8.33

New 90-day low: US$8.72

First quarter earnings released

Kewaunee Scientific Corporation to Report Q1, 2021 Results on Sep 08, 2020

New 90-day high - US$10.25

Kewaunee Scientific Corporation(NasdaqGM:KEQU) dropped from Russell Microcap Growth Index

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견